EFA has written letter in support of the following three bills, which all better regulate dangerous, harmful flavored tobacco:
- Maryland’s SB 410 (Kramer, Rosapepe, and West) – end the sale of vaping products that contain flavored tobacco
- Illinois’s HB 3887 (Wehrli, Ugaste, and McDermed) – end the sale of all flavored tobacco products
- New Jersey’s S1947 (Vitale, Singer, and Cunningham) – prohibit vendors from selling and distributing standard menthol and clove cigarettes
Assembly Bill 2293 (Mayes) is the Broadening Research, Education, Awareness, Treatment, and Health for Everyone with COPD (BREATHE with COPD) Act of 2020. AB 2293 aims to increase research, diagnosis, and funding for chronic obstructive pulmonary disease (COPD) and find new treatments that will help patients live longer and with a greater quality of life.
COPD is an umbrella term used to describe progressive lung diseases including emphysema, chronic bronchitis, and refractory asthma. This disease is characterized by increasing difficulty in breathing, wheezing, shortness of breath, and chest tightening. COPD is incurable, but it can be managed to slow the progression of the disease. Nationally, COPD is the fourth-leading cause of death, and in California, it is the fifth.
According to National Institute of Health findings, despite nearly 150,000 COPD-related deaths each year, government funding for disease research and programs is dwarfed by funding for other diseases. Among all diseases and conditions receiving research funding from the National Institutes of Health in 2019, COPD ranks 172nd. Because Washington will not step up to address this clear need, we need Sacramento to do its part.